A detailed history of Black Rock Inc. transactions in Nevro Corp stock. As of the latest transaction made, Black Rock Inc. holds 3,414,458 shares of NVRO stock, worth $28.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,414,458
Previous 3,374,031 1.2%
Holding current value
$28.7 Million
Previous $72.6 Million 32.1%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$13.56 - $20.78 $548,190 - $840,073
40,427 Added 1.2%
3,414,458 $49.3 Million
Q4 2023

Feb 13, 2024

BUY
$14.18 - $22.31 $3.46 Million - $5.45 Million
244,125 Added 7.8%
3,374,031 $72.6 Million
Q3 2023

Nov 13, 2023

BUY
$18.22 - $25.85 $1.94 Million - $2.76 Million
106,669 Added 3.53%
3,129,906 $60.2 Million
Q2 2023

Aug 11, 2023

SELL
$22.62 - $39.32 $3.59 Million - $6.25 Million
-158,826 Reduced 4.99%
3,023,237 $76.9 Million
Q1 2023

May 12, 2023

SELL
$30.17 - $41.11 $42.7 Million - $58.1 Million
-1,414,491 Reduced 30.77%
3,182,063 $115 Million
Q4 2022

Feb 13, 2023

SELL
$36.43 - $49.4 $10 Million - $13.6 Million
-274,968 Reduced 5.64%
4,596,554 $182 Million
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $1.22 Million - $1.59 Million
29,906 Added 0.62%
4,871,522 $227 Million
Q2 2022

Aug 12, 2022

BUY
$40.85 - $77.67 $5.01 Million - $9.53 Million
122,636 Added 2.6%
4,841,616 $212 Million
Q1 2022

May 12, 2022

BUY
$59.95 - $92.06 $34.1 Million - $52.4 Million
568,749 Added 13.7%
4,718,980 $341 Million
Q4 2021

Feb 10, 2022

BUY
$81.07 - $121.29 $11.4 Million - $17.1 Million
141,160 Added 3.52%
4,150,231 $336 Million
Q3 2021

Nov 09, 2021

BUY
$101.99 - $166.36 $4.22 Million - $6.89 Million
41,402 Added 1.04%
4,009,071 $467 Million
Q2 2021

Aug 11, 2021

BUY
$141.6 - $179.06 $562 Million - $710 Million
3,967,669 New
3,967,669 $658 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $298M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.